Mast Therapeutics, Inc. (MSTX) - NYSEMKT
From other sites
Company Description
Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis.... More
Sector: Healthcare
Industry: Biotechnology
Country: United States